The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is an aggressive childhood sarcoma with two distinct subtypes, embryonal (ERMS) and alveolar (ARMS) histologies. More effective treatment is needed to improve outcomes, beyond conventional cytotoxic chemotherapy. The pan-histone deacetylase inhibitor, Suberoylanilide Hydroxami...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Ther
Main Authors: Ghayad, Sandra E., Rammal, Ghina, Sarkis, Omar, Basma, Hussein, Ghamloush, Farah, Fahs, Assil, Karam, Mia, Harajli, Mohamad, Rabeh, Wissam, Mouawad, Joe E., Zalzali, Hassan, Saab, Raya
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6370390/
https://ncbi.nlm.nih.gov/pubmed/30307360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados